Icotrokinra demonstrated clinically meaningful outcomes at Week 28 in the Phase 2b ANTHEM-UC study in ulcerative colitis, with 31.7% of patients achieving clinical remission and 38.1% showing endoscop ...

Bristol Myers Squibb today announced Week 52 data from the pivotal Phase 3 POETYK PsA-1 trial further confirming the efficacy and safety of Sotyktu (deucravacitinib) in adults with active psoriatic ...

Beauty in 2025 is about intentional skincare and not indulgent hoarding. The secret to glowing skin isn’t in the number of ...

Q: I’m slated to retire next year, and it scares me to death — well, I hope not death, exactly, but I’m not sure what to do ...

INVH's Q3 results are likely to reflect strong demand for single-family rentals and tech-driven margin gains amid supply ...

Coya Therapeutics, Inc. (NASDAQ: COYA) ("Coya" or the "Company"), a clinical-stage biotechnology company focused on ...

For more serious resurfacing or skin tightening, you can go with a laser (Fraxel, CO2, Aerolase, IPL, RF, Laser Genesis). The ...

CIF number is important because it facilitates banking to be simpler and secure. With this number, the bank is able to verify ...

The key to growing older without feeling old hat is to keep evolving, while maintaining a strong sense of self.

Detailed price information for Arcutis Biotherapeutics Inc (ARQT-Q) from The Globe and Mail including charting and trades.